NCT01191099|UnknownDMC
Loading search results
observational
150
1 country
1
Study Start
August 2010
Date type not reportedThis date has not been verified as actual or estimated.
Primary Completion
August 2012
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Study Completion
August 2020
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
A single-center cohort study to identify uni- and multivariate associations between marker gene expression and clinico-pathological parameters for the detection of robust and novel prognostic tools in prostate cancer
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
August 2020
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Click on a node to explore related trials.
Some registry-reported names shown below are not yet linked in this graph.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
August 2010
Date type not reportedThis date has not been verified as actual or estimated.
August 25, 2010
Actual (reported)August 30, 2010
Actual (reported)August 2012
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
August 2020
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
0.5gm/m2 Pimonidazol i.v. 16-24 hours before prostatectomy
Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.
Patients with biopsy-proven adenocarcinoma of the prostate who are to be treated with radical prostatectomy at the Department of Urology, University Hospital of Zurich
University Hospital Zürich
Zurich, 8091, Switzerland
prostate
01 Studienregister MasterAdmins
UniversitaetsSpital Zuerich
Michael Müntener, MD
University Hospital Zurich, Division of urology
First Submitted
August 25, 2010
First Posted
August 30, 2010
Study Start
August 2010
Date type not reportedThis date has not been verified as actual or estimated.
Primary Completion
August 2012
Estimated (date passed)Everolimus as First-Line Therapy in Treating Patients With Prostate Cancer
Contact the study team to confirm eligibility.
This estimate has passed. The registry has not confirmed an actual date for this milestone.
Study Completion
August 2020
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Last Updated
November 8, 2011
Record last verified: 2011-11
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: